Predictors of Prostate Cancer at Fusion Biopsy: The Role of Positive Family History, Hypertension, Diabetes, and Body Mass Index.
Marco OderdaAlessandro DematteisGiorgio CallerisAdriana ContiDaniele D'AgateMarco FalconeAlessandro MarquisGabriele MontefuscoGiancarlo MarraPaolo GonteroPublished in: Current oncology (Toronto, Ont.) (2023)
In a series of patients selected for a fusion biopsy, positive family history, hypertension, diabetes, or BMI are not predictors of PCa detection. PSA-density and PI-RADS score are confirmed to be strong predictors of the CDR.
Keyphrases
- prostate cancer
- body mass index
- blood pressure
- type diabetes
- cardiovascular disease
- end stage renal disease
- radical prostatectomy
- weight gain
- ejection fraction
- ultrasound guided
- chronic kidney disease
- glycemic control
- newly diagnosed
- prognostic factors
- physical activity
- peritoneal dialysis
- loop mediated isothermal amplification
- weight loss
- insulin resistance
- quantum dots
- label free